These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 27712852

  • 1. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials.
    Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA.
    Am J Kidney Dis; 2017 Jan; 69(1):78-86. PubMed ID: 27712852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
    Catalá-López F, Macías Saint-Gerons D, González-Bermejo D, Rosano GM, Davis BR, Ridao M, Zaragoza A, Montero-Corominas D, Tobías A, de la Fuente-Honrubia C, Tabarés-Seisdedos R, Hutton B.
    PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482
    [Abstract] [Full Text] [Related]

  • 4. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H.
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [Abstract] [Full Text] [Related]

  • 5. Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
    Fletcher RA, Jongs N, Chertow GM, McMurray JJV, Arnott C, Jardine MJ, Mahaffey KW, Perkovic V, Rockenschaub P, Rossing P, Correa-Rotter R, Toto RD, Vaduganathan M, Wheeler DC, Heerspink HJL, Neuen BL.
    J Am Soc Nephrol; 2023 Dec 01; 34(12):1965-1975. PubMed ID: 37876229
    [Abstract] [Full Text] [Related]

  • 6. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.
    Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J.
    Diabetologia; 2012 Mar 01; 55(3):566-78. PubMed ID: 22189484
    [Abstract] [Full Text] [Related]

  • 7. Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials.
    Liao RX, Lyu XF, Tang WJ, Gao K.
    Clin Transplant; 2017 Apr 01; 31(4):. PubMed ID: 28186357
    [Abstract] [Full Text] [Related]

  • 8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018 Jan 11; 50(6):1834-1837. PubMed ID: 30056910
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria.
    Coleman CI, Weeda ER, Kharat A, Bookhart B, Baker WL.
    Diabet Med; 2020 Jan 11; 37(1):44-52. PubMed ID: 31407377
    [Abstract] [Full Text] [Related]

  • 14. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May 11; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 11; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 17. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018 Sep 11; 50(6):1838-1841. PubMed ID: 30056911
    [Abstract] [Full Text] [Related]

  • 18. Effects of renin-angiotensin system blockade on mortality and hospitalization in heart failure with preserved ejection fraction.
    Agarwal V, Briasoulis A, Messerli FH.
    Heart Fail Rev; 2013 Jul 11; 18(4):429-37. PubMed ID: 22678768
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.
    Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH.
    BMJ; 2013 Jan 28; 346():f360. PubMed ID: 23358488
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.